Rep. Julie Johnson Sells Off Shares of Procter & Gamble Company (The) (NYSE:PG)

Representative Julie Johnson (D-Texas) recently sold shares of Procter & Gamble Company (The) (NYSE:PG). In a filing disclosed on December 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in Procter & Gamble stock on November 13th. The trade occurred in the Representative’s “CHASE BROKERAGE ACCOUNT (3935)” account.

Representative Julie Johnson also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Charles Schwab (NYSE:SCHW) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Cigna Group (NYSE:CI) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Xcel Energy (NASDAQ:XEL) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Capital One Financial (NYSE:COF) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Walmart (NASDAQ:WMT) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Seagate Technology (NASDAQ:STX) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Wells Fargo & Company (NYSE:WFC) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Texas Instruments (NASDAQ:TXN) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of The Goldman Sachs Group (NYSE:GS) on 11/13/2025.

Procter & Gamble Trading Down 1.6%

Shares of PG stock traded down $2.31 on Thursday, reaching $145.50. 11,344,993 shares of the stock were exchanged, compared to its average volume of 10,694,314. The company has a debt-to-equity ratio of 0.46, a current ratio of 0.71 and a quick ratio of 0.51. Procter & Gamble Company has a one year low of $138.14 and a one year high of $179.99. The stock has a market cap of $339.99 billion, a PE ratio of 21.24, a P/E/G ratio of 4.97 and a beta of 0.39. The stock has a 50 day moving average price of $147.42 and a 200 day moving average price of $153.72.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Friday, October 24th. The company reported $1.99 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.09. The firm had revenue of $22.39 billion during the quarter, compared to analyst estimates of $22.23 billion. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The company’s revenue was up 3.0% on a year-over-year basis. During the same period last year, the company earned $1.93 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Equities research analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, November 17th. Stockholders of record on Friday, October 24th were paid a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend was Friday, October 24th. Procter & Gamble’s dividend payout ratio (DPR) is 61.75%.

Analyst Ratings Changes

Several equities research analysts have recently commented on PG shares. JPMorgan Chase & Co. lowered their price target on shares of Procter & Gamble from $165.00 to $157.00 and set a “neutral” rating for the company in a research report on Thursday. BNP Paribas Exane lowered their target price on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a report on Tuesday, September 23rd. UBS Group cut their price target on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a research note on Monday. Finally, Jefferies Financial Group raised Procter & Gamble from a “hold” rating to a “buy” rating and increased their target price for the company from $156.00 to $179.00 in a research note on Tuesday. Thirteen analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $171.38.

Institutional Trading of Procter & Gamble

Hedge funds have recently added to or reduced their stakes in the business. Advisors Management Group Inc. ADV grew its stake in Procter & Gamble by 1.2% in the third quarter. Advisors Management Group Inc. ADV now owns 27,792 shares of the company’s stock valued at $4,270,000 after acquiring an additional 334 shares during the period. Lindenwold Advisors INC lifted its holdings in shares of Procter & Gamble by 0.9% during the 3rd quarter. Lindenwold Advisors INC now owns 15,406 shares of the company’s stock valued at $2,367,000 after purchasing an additional 141 shares in the last quarter. Farmers National Bank grew its position in shares of Procter & Gamble by 3.4% in the 3rd quarter. Farmers National Bank now owns 50,831 shares of the company’s stock valued at $7,810,000 after purchasing an additional 1,692 shares during the period. Painted Porch Advisors LLC increased its stake in Procter & Gamble by 1.1% during the 3rd quarter. Painted Porch Advisors LLC now owns 14,386 shares of the company’s stock worth $2,210,000 after purchasing an additional 150 shares in the last quarter. Finally, Saranac Partners Ltd acquired a new stake in Procter & Gamble during the 3rd quarter worth approximately $30,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Transactions at Procter & Gamble

In related news, CEO Jon R. Moeller sold 11,684 shares of the company’s stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $1,778,655.32. Following the completion of the transaction, the chief executive officer directly owned 319,932 shares of the company’s stock, valued at approximately $48,703,248.36. This represents a 3.52% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Andre Schulten sold 4,252 shares of the stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $647,281.96. Following the transaction, the chief financial officer owned 53,992 shares of the company’s stock, valued at approximately $8,219,202.16. This trade represents a 7.30% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 30,308 shares of company stock valued at $4,611,852. 0.20% of the stock is currently owned by insiders.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.

Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.